Search results
A Monoclonal Antibody Could Help Fight Malaria
Medscape· 1 day agoMalaria is the world's leading parasite-related endemic disease. Infections caused by Plasmodium falciparum, the deadly species, are the most common and...
Invivyd reports antibody neutralization of new COVID variants By Investing.com
Investing.com· 21 hours agoInvivyd, Inc. (NASDAQ:IVVD), a biopharmaceutical company, announced today that its investigational ...
FDA panel votes unanimously for Eli Lilly's Alzheimer's treatment
Yahoo Finance· 5 days agoAn FDA panel voted 11-0 Monday to recommend the use of Eli Lilly's (LLY) early-stage Alzheimer's...
Eli Lilly's Alzheimer's Drug Gains Unanimous FDA Panel Backing
Verywell Health via Yahoo News· 4 days agoAn FDA advisory panel endorsed donanemab, Eli Lilly’s monoclonal antibody drug designed to slow the...
Selecting An R&D Data Management Platform To Support The Development Of Novel Antibody-Based...
EnterpriseContentManagementConnection-ECM· 5 days agoProPharma assisted a commercial-stage biotech company near Munich in selecting an R&D data...
New EHA data reveal how badly Gilead's $4.9B bet on CD47 imploded
FierceBiotech· 17 hours agoGilead Sciences' abandoned anti-CD47 drug magrolimab was not just ineffective, but could potentially...
Alzheimer’s Disease Drug Donanemab Gets Unanimous Backing From FDA Expert Panel
Forbes· 4 days agoA Food and Drug Administration expert panel of advisors voted 11-0 yesterday to recommend that the...
AbbVie and FutureGen link on inflammatory bowel disease
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe asset is currently in the preclinical development phase. A fully human monoclonal antibody,...
FDA advisors recommend Eli Lilly's Alzheimer's drug donanemab, paving way for approval
CNBC· 5 days agoEli Lilly & Co.'s shares climbed in early US trading after its experimental drug for Alzheimer's...
FDA advisers endorse Eli Lilly’s early-stage Alzheimer’s drug donanemab
CNN via Yahoo News· 4 days agoOn Monday, a panel of independent advisers to the US Food and Drug Administration voted to endorse Eli Lilly’s drug donanemab, a monoclonal antibody designed ...